Theodore Logan
Program Leader - Melanoma · Indiana University School of Medicine
Credentials: · · ·
History
Research
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Journal of Clinical Oncology · 2015 · 901 citations
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
The Lancet Oncology · 2012 · 895 citations
Journal of Clinical Oncology · 2004 · 779 citations
18 papers
13 papers
13 papers
13 papers
13 papers
12 papers
11 papers
8 papers
Grants
- 2003–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $4.6K · Indiana University Indianapolis
Clinical trials
- 2006–2013
The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma
Principal investigator · Completed · Phase 2
Beth Israel Deaconess Medical Center
- 2004–2027
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
Principal investigator · Active not recruiting
Indiana University